业绩清单

一、  承担的科研项目

(1) 非共价键作用力介导苝酰亚胺实现肺特异性分布及抗肺癌性能，国家自然科学基金（编号：22175055，2022.01–2025.12，资助金额78万）。

二、代表性科研论文

(1) Zhonghua Liu, Xuejuan Wang, Qing Chen, Feiyan Ma, Yongwei Huang*, Yijian Gao, Qingyuan Deng, Zeng-Ying Qiao*, Xiaoyi Xing, Jianling Zhu, Feng Lu*, and Hao Wang*, Regulating Twisted Skeleton to Construct Organ-Specific Perylene for Intensive Cancer Chemotherapy, Angew. Chem. Int. Ed., 2021, 60, 16215–16233. (顶级期刊, IF = 15.33, VIP 论文).

(2) Rijie Zheng, Qi Zhao, Weixia Qing, Shengliang Li, Zhonghua Liu*, Qianqian Li, and Yongwei Huang*, Carrier-Free Delivery of Ultra-small π-Conjugated Oligomer Nanoparticles with Photothermal Conversion over 80% for Cancer Theranostics, Small, 2021, 2104521. (SCI一区, IF = 13.3).

(3) Fang Liu, Feiyan Ma, Qing Chen, Enbao Zhou, Puwen Zhang, Zhanjun Cui,* Zhonghua Liu, and Yongwei Huang,* Synergistic non-bonding interactions based on diketopyrrolo-pyrrole for elevated photoacoustic imaging-guided photothermal therapy, Biomater. Sci., 2021, 9, 908–916. (SCI 二区，IF = 6.84)

(4) Xin Jin, Xiaoyi Xing, Qingyuan Deng, Weixia Qing,* Zhonghua Liu* and Yongwei Huang, Molecular engineering of diketopyrrolopyrroleconjugated polymer nanoparticles by chalcogenide variation for photoacoustic imaging guided photothermal therapy, J. Mater. Chem. B., 2021, 9, 3153–3160. (SCI 二区，IF = 6.33)

三、发明专利

(1) 一种苝酰亚胺衍生物及应用，国家发明专利，中国，2021, 11, 09授权，黄永伟，刘中华，王颖哲，马翡雁，高一剑，专利号：ZL 202011603976.X（已申报国际专利）。